ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
生物医药B类股
557.223
+22.375
4.18%
手动刷新
涨家数:
24
跌家数:
8
平家数:
2
市盈率:
- -
高:
561.530
开:
534.650
低:
532.866
收:
534.848
数据加载中...
总览
新闻资讯
泓德基金:上周权益市场窄幅震荡,创新药板块表现亮眼
新浪基金
·
06-09
A股收评:三大股指震荡上升 创新药板块持续爆发
美港电讯
·
06-09
【大参林成立综合门诊公司,含医疗美容服务业务】 公开资料显示,近日,广西大参林参柳综合门诊有限公司成立,法定代表人为潘国律,注册资本为100万元,经营范围包含:医疗服务;药品零售;第三类医疗器械经营;食品互联网销售;医疗器械互联网信息服务;中药饮片代煎服务;医疗美容服务等。股权数据显示,该公司由大参林间接全资持股。
金融界
·
06-09
李氏大药厂盘中异动 下午盘股价大涨5.59%
市场透视
·
06-09
半夏投资李蓓:我错过了小微盘、新消费、科技和创新药,但依然坚持自己的框架和体系
华尔街见闻
·
06-09
美媒:中国持续对美制医药开放市场
上观新闻
·
06-09
【九安医疗成立新公司 含智能无人飞行器相关业务】 公开资料显示,近日,德州九博电子科技有限公司成立,法定代表人为李康,经营范围包含:非公路休闲车及零配件销售;智能无人飞行器销售;第一类医疗器械销售;第二类医疗器械销售等。股权数据显示,该公司由九安医疗全资持股。
金融界
·
06-09
火爆!涨停潮来了!
市场资讯
·
06-09
创新药爆发 机构表示看好行业有望迎来系统性投资机会
美港电讯
·
06-09
药明巨诺-B午前涨超7% 近日宣布CAR-T产品“瑞基奥仑赛“在中国澳门获批上市
智通财经
·
06-09
云顶新耀盘中涨超14% BTK抑制剂EVER001相关研究数据首次亮相ERA 2025大会
智通财经
·
06-09
A股午评:沪指涨0.23% 盘中一度收复3400点整数关口
美港电讯
·
06-09
永泰生物-B(06978)股价上升8.228%,现价港币$3.42
阿斯达克财经
·
06-09
科济药业-B盘中异动 早盘股价大涨5.21%报20.200港元
市场透视
·
06-09
德琪医药-B盘中异动 早盘股价大涨5.21%报3.840港元
市场透视
·
06-09
亚盛医药-B盘中异动 大幅上涨5.05%报58.200港元
市场透视
·
06-09
星昊医药29.96%涨停,总市值31.45亿元
金融界
·
06-09
云顶新耀新型BTK抑制剂EVER001的1b/2a期临床试验积极结果首次亮相第62届欧洲肾脏协会大会
格隆汇
·
06-09
医疗器械板块盘中走强,热景生物领涨8.97%
金融界
·
06-09
嘉和生物-B盘中异动 股价大涨5.91%报2.690港元
市场透视
·
06-09
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":557.22327,"timestamp":1749542910677,"preClose":534.8484,"halted":0,"volume":296752405,"delay":0,"changeRate":0.041834,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":22.374878,"latestTime":"06-10 16:00:00","open":534.64966,"high":561.53046,"low":532.8655,"amount":6842878404,"amplitude":0.053595,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1749605400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749519000000,1749528000000],[1749531600000,1749542400000]],"pbRate":4.413457,"peRate":-27.18022,"turnoverRate":0.011177,"increases":24,"decrements":5,"flats":4,"marketCap":323938341120,"floatMarketCap":298441848048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":561.53046,"amplitude":0.053595,"preClose":534.8484,"low":532.8655,"pbRate":"4.413457","latestPrice":557.22327,"volume":296752405,"delay":0,"open":534.64966,"prevYearClose":331.1933,"prevWeekClose":504.495,"prevMonthClose":491.683,"prevQuarterClose":455.082,"fiveDayClose":491.473,"twentyDayClose":447.877,"sixtyDayClose":422.518,"secType":"PLATE","market":"HK","turnoverRate":0.011177,"peRate":-27.18022,"marketCap":323938341120,"floatMarketCap":298441848048,"timestamp":1749542910677,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":24,"down":8,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542803115","title":"泓德基金:上周权益市场窄幅震荡,创新药板块表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2542803115","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542803115?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 15:19","pubTimestamp":1749453540,"startTime":"0","endTime":"0","summary":"上周是端午假期前的最后一个交易周,国内权益市场呈现窄幅震荡格局,主要宽基指数涨跌幅在1%附近,万得全A周振幅为1.4%,全周几乎收平,日均成交量维持在1.1万亿附近,创新药板块是上周为数不多的亮点。泓德基金表示,投资者对此也无需过分担忧,短暂的事件扰动更多属于情绪作用,对于反复变动的关税市场或正在逐渐脱敏,回到基本面驱动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-06-09/doc-ineznhpe6592668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1574","BK1161","159992"],"gpt_icon":0},{"id":"2542913808","title":"A股收评:三大股指震荡上升 创新药板块持续爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2542913808","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542913808?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 15:05","pubTimestamp":1749452758,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a6a63c3d48f93410ff198e41f4772c5f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300651","BK0188","002250","LU1831875114.USD","BK0229","300255","BK0132","BK0242","01787","160636","LU0463099449.HKD","BK0116","BK1198","159992","399001","LU0181495838.USD","06978","300584","BK0012","SGXZ81163826.USD","SGXZ49509284.SGD","BK0070","399300","600547","BK1592","300204","605099","BK0196","BK0046","BK0077","BK0118","BK1161","002317","159982","LU0140636845.USD","600988","LU1188198961.HKD","399006","LU0244354667.USD","BK0177","BK0183","BK0239","BK0028","300149","BK0216","06693","BK1544","BK0172","159792","BK1574"],"gpt_icon":0},{"id":"2542780853","title":"【大参林成立综合门诊公司,含医疗美容服务业务】 公开资料显示,近日,广西大参林参柳综合门诊有限公司成立,法定代表人为潘国律,注册资本为100万元,经营范围包含:医疗服务;药品零售;第三类医疗器械经营;食品互联网销售;医疗器械互联网信息服务;中药饮片代煎服务;医疗美容服务等。股权数据显示,该公司由大参林间接全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542780853","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542780853?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 14:48","pubTimestamp":1749451682,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,广西大参林参柳综合门诊有限公司成立,法定代表人为潘国律,注册资本为100万元,经营范围包含:医疗服务;药品零售;第三类医疗器械经营;食品互联网销售;医疗器械互联网信息服务;中药饮片代煎服务;医疗美容服务等。股权数据显示,该公司由大参林间接全资持股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09144850944356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159883","603233","BK0185","BK1222","159792","BK1583","160636","III","BK4134","BK1100","09996","BK1574","09997","BK0209","BK0114"],"gpt_icon":0},{"id":"2542721258","title":"李氏大药厂盘中异动 下午盘股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542721258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542721258?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 13:24","pubTimestamp":1749446670,"startTime":"0","endTime":"0","summary":"2025年06月09日下午盘13时24分,李氏大药厂股票出现波动,股价急速上涨5.59%。截至发稿,该股报1.510港元/股,成交量12.35万股,换手率0.02%,振幅2.80%。李氏大药厂股票所在的药品行业中,整体涨幅为1.21%。其相关个股中,四环医药、九源基因、东阳光长江药业涨幅较大,振幅较大的相关个股有四环医药、三生制药、九源基因,振幅分别为16.50%、13.27%、12.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091324309777536d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091324309777536d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1574","06622","BK1587","BK1191","BK1583"],"gpt_icon":1},{"id":"2542872583","title":"半夏投资李蓓:我错过了小微盘、新消费、科技和创新药,但依然坚持自己的框架和体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2542872583","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542872583?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 13:23","pubTimestamp":1749446631,"startTime":"0","endTime":"0","summary":"半夏投资李蓓认为,过去两年政策落地效果不及预期,从政策建议到执行的比例大幅下降,持续时间变短,这成为近期投资失误的主要原因,但仍选择继续持有低估值、高股息的建筑央企和地产股等,认为长期来看这些标的更具安全性和回报潜力。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/c217c8f7-00c5-4d24-93a7-89faf3bcf09f.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/c217c8f7-00c5-4d24-93a7-89faf3bcf09f.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3748729","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3748729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2542872637","title":"美媒:中国持续对美制医药开放市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2542872637","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542872637?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 13:16","pubTimestamp":1749446160,"startTime":"0","endTime":"0","summary":"过去十年间,中国向美国先进药品开放市场,近期更将医疗产品排除在报复性关税清单之外。上个月中美贸易战休战后,中国对美商品加征关税税率设定为10%,而医疗物资在豁免清单之列,包括疫苗、诊断用化学试剂、手术黏合剂等。中国约有一半的成年人肥胖或超重。中国是仿制药生产大国,基本药品和疫苗广泛可及。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-06-09/doc-ineznafr0011628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","09939","BK1515","159938"],"gpt_icon":0},{"id":"2542078874","title":"【九安医疗成立新公司 含智能无人飞行器相关业务】 公开资料显示,近日,德州九博电子科技有限公司成立,法定代表人为李康,经营范围包含:非公路休闲车及零配件销售;智能无人飞行器销售;第一类医疗器械销售;第二类医疗器械销售等。股权数据显示,该公司由九安医疗全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542078874","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542078874?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 13:06","pubTimestamp":1749445600,"startTime":"0","endTime":"0","summary":"公开资料显示,近日,德州九博电子科技有限公司成立,法定代表人为李康,经营范围包含:非公路休闲车及零配件销售;智能无人飞行器销售;第一类医疗器械销售;第二类医疗器械销售等。股权数据显示,该公司由九安医疗全资持股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/09130650943317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09996","BK0114","BK0146","BK1100","002432","159883","BK1583","BK1222","BK1574","BK0251","09997","BK0109"],"gpt_icon":0},{"id":"2542874050","title":"火爆!涨停潮来了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2542874050","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542874050?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 12:59","pubTimestamp":1749445140,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 创新药概念大爆发,军工龙头股中航沈飞涨停。 6月9日上午,A股市场震荡上行,上证指数一度收复3400点。截至午前收盘,上证指数涨0.23%,深证成指涨0.62%,创业板指涨1.22%,北证50指数涨1.08%。消费股有所反弹,泡泡玛特涨1.63%,蜜雪集团涨6.8%,布鲁可涨超18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-06-09/doc-ineznafn1304088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2542983874","title":"创新药爆发 机构表示看好行业有望迎来系统性投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2542983874","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542983874?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 12:44","pubTimestamp":1749444284,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159938","BK0082","06978","BK1515","BK1191","BK0250","BK1574","BK4080","01477","BK0185","159982","399300","600056","BK0010","BK0028","09939","BK0175","159992","BK0188","161027","BK4231","ADC","BK1161"],"gpt_icon":0},{"id":"2542787176","title":"药明巨诺-B午前涨超7% 近日宣布CAR-T产品“瑞基奥仑赛“在中国澳门获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2542787176","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542787176?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 11:48","pubTimestamp":1749440896,"startTime":"0","endTime":"0","summary":"药明巨诺-b午前涨超7%,截至发稿,涨7.69%,报1.96港元,成交额495.34万港元。消息面上,6月4日,药明巨诺宣布,其自主开发的靶向CD19自体CAR-T细胞免疫治疗产品瑞基奥仑赛注射液的新药上市许可申请获得中国澳门药物监督管理局批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609115455a49fb19d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609115455a49fb19d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2542871969","title":"云顶新耀盘中涨超14% BTK抑制剂EVER001相关研究数据首次亮相ERA 2025大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2542871969","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542871969?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 11:39","pubTimestamp":1749440357,"startTime":"0","endTime":"0","summary":"云顶新耀盘中涨超14%,截至发稿,涨12.28%,报53.5港元,成交额4.76亿港元。据介绍,EVER001是一款适用于自身免疫性肾脏疾病的共价可逆BTK抑制剂。与共价不可逆BTK抑制剂相比,EVER001作为一款潜在的同类最佳产品,在保持高活性的同时具有高选择性,避免持续抑制带来的毒副作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609114457a6ffe7de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609114457a6ffe7de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01952","BK1583"],"gpt_icon":0},{"id":"2542879261","title":"A股午评:沪指涨0.23% 盘中一度收复3400点整数关口","url":"https://stock-news.laohu8.com/highlight/detail?id=2542879261","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542879261?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 11:36","pubTimestamp":1749440164,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","BK0250","BK0172","BK0211","BK0001","BK0004","600158","BK0283","BK0132","002250","BK0098","BK0188","300149","BK0239","08058","159982","BK0229","605099","BK0077","BK0040","06978","399001","BK1574","BK0254","BK0115","BK0216","BK0118","BK0082","BK0201","301263","159715","002317","159992","161121","002793","BK0070","BK0178","BK0028","BK0116","399006","300255","BK1161"],"gpt_icon":0},{"id":"2542794298","title":"永泰生物-B(06978)股价上升8.228%,现价港币$3.42","url":"https://stock-news.laohu8.com/highlight/detail?id=2542794298","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542794298?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 11:15","pubTimestamp":1749438900,"startTime":"0","endTime":"0","summary":"[上升股]永泰生物-B(06978) 股价在上午11:15比前收市价上升8.228%,现股价为港币$3.42。至目前为止,今日最高价为$3.42,而最低价为$3.15。总成交量为25.3万股,总成交金额为港币$82.092万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2506093647/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2542876415","title":"科济药业-B盘中异动 早盘股价大涨5.21%报20.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542876415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542876415?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:43","pubTimestamp":1749437035,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘10时43分,科济药业-B股票出现异动,股价急速拉升5.21%。截至发稿,该股报20.200港元/股,成交量117.15万股,换手率0.20%,振幅7.29%。资金方面,该股资金流入1481.45万港元,流出627.344万港元。机构评级方面,在所有1家参与评级的机构中,100%的券商给予卖出建议,无券商给予买入、持有建议。科济药业-B股票所在的生物技术行业中,整体涨幅为3.86%。科济药业-B公司简介:科济药业控股有限公司是一家主要从事探索、研发细胞疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091043559514194f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506091043559514194f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1585","02171","BK1587","BK1574"],"gpt_icon":0},{"id":"2542079875","title":"德琪医药-B盘中异动 早盘股价大涨5.21%报3.840港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542079875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542079875?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:36","pubTimestamp":1749436567,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘10时36分,德琪医药-B股票出现波动,股价急速拉升5.21%。截至发稿,该股报3.840港元/股,成交量159.3万股,换手率0.23%,振幅6.30%。资金方面,该股资金流入377.954万港元,流出148.753万港元。德琪医药-B股票所在的药品行业中,整体涨幅为0.64%。其相关个股中,凯莱英、绿叶制药、东阳光长江药业涨幅较大,振幅较大的相关个股有和黄医药、三生制药、信达生物,振幅分别为10.37%、9.80%、9.09%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609103607a49f9a1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609103607a49f9a1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"2542187507","title":"亚盛医药-B盘中异动 大幅上涨5.05%报58.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542187507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542187507?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:30","pubTimestamp":1749436221,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘10时30分,亚盛医药-B股票出现异动,股价急速上涨5.05%。截至发稿,该股报58.200港元/股,成交量239.02万股,换手率0.69%,振幅5.78%。资金方面,该股资金流入7665.43万港元,流出4652.46万港元。亚盛医药-B股票所在的生物技术行业中,整体涨幅为3.56%。其相关个股中,帝王国际投资、金斯瑞生物科技、中国抗体-B涨幅较大,振幅较大的相关个股有帝王国际投资、中国抗体-B、欧康维视生物-B,振幅分别为32.91%、16.90%、15.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060910302197772205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060910302197772205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06855","BK1161"],"gpt_icon":0},{"id":"2542752608","title":"星昊医药29.96%涨停,总市值31.45亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542752608","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542752608?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:19","pubTimestamp":1749435597,"startTime":"0","endTime":"0","summary":"6月9日,星昊医药盘中29.96%涨停,截至10:19,报25.72元/股,成交3.48亿元,换手率12.38%,总市值31.45亿元。资料显示,北京星昊医药股份有限公司位于北京经济技术开发区中和街18号,公司专注于为全球医药行业提供新药和仿制药的定制研发与生产服务,涵盖从临床研究到药品上市的全生命周期。截至9月30日,星昊医药股东户数7571,人均流通股1.04万股。2024年1月-9月,星昊医药实现营业收入4.68亿元,同比减少9.91%;归属净利润7877.01万元,同比增长8.22%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/09101950940674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159938","BK1515","BK1161","09939","BK1574"],"gpt_icon":0},{"id":"2542387504","title":"云顶新耀新型BTK抑制剂EVER001的1b/2a期临床试验积极结果首次亮相第62届欧洲肾脏协会大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387504","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542387504?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:11","pubTimestamp":1749435081,"startTime":"0","endTime":"0","summary":"EVER001是一款适用于自身免疫性肾脏疾病的共价可逆BTK抑制剂。共有31名经肾脏活检证实的抗PLA2R自身抗体阳性的原发性膜性肾病患者分别入组低剂量组和高剂量组,接受EVER001共36周的治疗。非常高兴看到EVER001临床试验阶段性数据的积极结果首次在国际学术大会上公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060910114297771b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060910114297771b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1576","BK1583","BK1141","03347","01952"],"gpt_icon":0},{"id":"2542873048","title":"医疗器械板块盘中走强,热景生物领涨8.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542873048","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542873048?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:10","pubTimestamp":1749435057,"startTime":"0","endTime":"0","summary":"6月9日,医疗器械板块盘中上涨1.51%,热景生物领涨8.97%,爱迪特涨超6%,诺唯赞、伟思医疗、华大基因涨超5%。板块实时资金流向显示,今日超大单净流入3017.61万元,今日小单净流出7906.76万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/09101050940477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688068","09997","BK1222","09996","BK1100","BK1574","BK0239","BK1583","159883"],"gpt_icon":0},{"id":"2542695875","title":"嘉和生物-B盘中异动 股价大涨5.91%报2.690港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542695875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542695875?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 10:10","pubTimestamp":1749435038,"startTime":"0","endTime":"0","summary":"2025年06月09日早盘10时10分,嘉和生物-B股票出现异动,股价急速上涨5.91%。截至发稿,该股报2.690港元/股,成交量18.4万股,换手率0.04%,振幅6.30%。资金方面,该股资金流入46.841万港元,流出1.1535万港元。嘉和生物-B股票所在的生物技术行业中,整体涨幅为2.83%。其相关个股中,帝王国际投资、金斯瑞生物科技、中国抗体-B涨幅较大,振幅较大的相关个股有帝王国际投资、中国抗体-B、欧康维视生物-B,振幅分别为32.91%、16.90%、13.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609101039a49f9214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609101039a49f9214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","06998"],"gpt_icon":0}],"pageSize":20,"totalPage":34,"pageCount":7,"totalSize":674,"code":"91000000","status":"200"}]}}